{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:01:16Z","timestamp":1784325676806,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.metabol.2024.156054","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T10:43:42Z","timestamp":1730457822000},"page":"156054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation"],"prefix":"10.1016","volume":"162","author":[{"given":"Chuangpeng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.156054_bb0005","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2024.156054_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156054_bb0015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156054_bb0020","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.metabol.2024.156054_bb0025","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","article-title":"Hepatic Kr\u00fcppel-like factor 16 (KLF16) targets PPAR\u03b1 to improve steatohepatitis and insulin resistance","volume":"70","author":"Sun","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.156054_bb0030","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1242\/jcs.03280","article-title":"Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4","volume":"119","author":"Milger","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2024.156054_bb0035","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1074\/jbc.M701779200","article-title":"Keratinocyte-specific expression of fatty acid transport protein 4 rescues the wrinkle-free phenotype in Slc27a4\/Fatp4 mutant mice","volume":"282","author":"Moulson","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.156054_bb0040","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1523\/JNEUROSCI.2428-12.2013","article-title":"Fatty acid transport protein 4 (FATP4) prevents light-induced degeneration of cone and rod photoreceptors by inhibiting RPE65 isomerase","volume":"33","author":"Li","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2024.156054_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000361","article-title":"Methionine- and choline-deficient diet enhances adipose lipolysis and leptin release in aP2-Cre Fatp4-knockout mice","volume":"64","author":"Cheng","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.metabol.2024.156054_bb0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lipd.12029","article-title":"Sex-specific alterations in serology and the expression of liver FATP4 protein in offspring exposed to high-fat diet during pregnancy and\/or lactation","volume":"53","author":"Zhao","year":"2018","journal-title":"Lipids"},{"key":"10.1016\/j.metabol.2024.156054_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3748\/wjg.v24.i3.323","article-title":"circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling","volume":"24","author":"Guo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2024.156054_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.959902","article-title":"The role of pregnane X receptor (PXR) in substance metabolism","volume":"13","author":"Lv","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2024.156054_bb0065","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/17425255.4.7.895","article-title":"The pregnane X receptor: from bench to bedside","volume":"4","author":"Ma","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.metabol.2024.156054_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1389200054633826","article-title":"Regulation of hepatic transporters by xenobiotic receptors","volume":"6","author":"Klaassen","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.metabol.2024.156054_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114698","article-title":"Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature","volume":"193","author":"Kim","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2024.156054_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2009.10.035","article-title":"The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population","volume":"210","author":"Lu","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2024.156054_bb0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.114.097287","article-title":"SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver","volume":"87","author":"Li","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2024.156054_bb0090","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/mol.107.041012","article-title":"Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression","volume":"73","author":"Roth","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2024.156054_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/me.2014-1355","article-title":"Intestinal pregnane X receptor links xenobiotic exposure and hypercholesterolemia","volume":"29","author":"Sui","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2024.156054_bb0100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","article-title":"Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis","volume":"134","author":"Zhou","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.156054_bb0105","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.156054_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.156054_bb0115","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/db12-1039","article-title":"PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156054_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tox.2018.08.007","article-title":"Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease","volume":"410","author":"Li","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.metabol.2024.156054_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e328333a1dd","article-title":"The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease","volume":"20","author":"Sookoian","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.metabol.2024.156054_bb0130","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gutjnl-2020-320853","article-title":"Loss of hepatic Mboat7 leads to liver fibrosis","volume":"70","author":"Thangapandi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.156054_bb0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156054_bb0140","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.30411","article-title":"Thioesterase superfamily member 2 promotes hepatic VLDL secretion by channeling fatty acids into triglyceride biosynthesis","volume":"70","author":"Alves-Bezerra","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156054_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18632\/aging.100652","article-title":"Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease","volume":"6","author":"Sheedfar","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.metabol.2024.156054_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2024.156054_bb0155","doi-asserted-by":"crossref","first-page":"2002273","DOI":"10.1002\/advs.202002273","article-title":"The nuclear orphan receptor NR2F6 promotes hepatic steatosis through upregulation of fatty acid transporter CD36","volume":"7","author":"Zhou","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.metabol.2024.156054_bb0160","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2024.156054_bb0165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2021.0157","article-title":"Inhibition of fatty acid translocase (FAT\/CD36) palmitoylation enhances hepatic fatty acid \u03b2-oxidation by increasing its localization to mitochondria and interaction with long-chain acyl-CoA synthetase 1","volume":"36","author":"Zeng","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2024.156054_bb0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2009.03.003","article-title":"PXR and CAR in energy metabolism","volume":"20","author":"Wada","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.156054_bb0175","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.1074\/jbc.M610072200","article-title":"Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver","volume":"282","author":"Nakamura","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.156054_bb0180","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1074\/jbc.M113.494575","article-title":"Role of pregnane X receptor in obesity and glucose homeostasis in male mice","volume":"289","author":"Spruiell","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.156054_bb0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcp.2017.07.019","article-title":"Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression","volume":"142","author":"Zhao","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2024.156054_bb0190","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","article-title":"Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms","volume":"89","author":"Bitter","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.metabol.2024.156054_bb0195","doi-asserted-by":"crossref","unstructured":"Lee, C.G., Lee, S.J., Park, S., Choi, S.E., Song, M.W., Lee, H.W., Kim, H.J., Kang, Y., Lee, K.W., Kim, H.M., et al. (2022). In vivo two-photon imaging analysis of dynamic degradation of hepatic lipid droplets in MS-275-treated mouse liver. Int J Mol Sci 23.","DOI":"10.3390\/ijms23179978"},{"key":"10.1016\/j.metabol.2024.156054_bb0200","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156054_bb0205","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41467-018-03060-y","article-title":"AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle","volume":"9","author":"Kim","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2024.156054_bb0210","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.hbpd.2021.05.008","article-title":"LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver","volume":"20","author":"Wang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.metabol.2024.156054_bb0215","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.24782","article-title":"Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice","volume":"55","author":"Ling","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156054_bb0220","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/liv.14174","article-title":"Total liver phosphatidylcholine content associates with non-alcoholic steatohepatitis and glycine N-methyltransferase expression","volume":"39","author":"M\u00e4nnist\u00f6","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2024.156054_bb0225","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.156054_bb0230","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1139\/apnm-2012-0261","article-title":"Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine","volume":"38","author":"Arendt","year":"2013","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.metabol.2024.156054_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169296","article-title":"Hepatic PEMT expression decreases with increasing NAFLD severity","volume":"23","author":"Piras","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2024.156054_bb0240","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1096\/fj.201900679R","article-title":"Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance","volume":"33","author":"Wan","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2024.156054_bb0245","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.metabol.2024.156054_bb0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20080740","article-title":"Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway","volume":"417","author":"Finn","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2024.156054_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.aquatox.2012.03.005","article-title":"Daphnia HR96 is a promiscuous xenobiotic and endobiotic nuclear receptor","volume":"116-117","author":"Karimullina","year":"2012","journal-title":"Aquat Toxicol"},{"key":"10.1016\/j.metabol.2024.156054_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jnutbio.2017.01.011","article-title":"A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in mice","volume":"42","author":"Saraswathi","year":"2017","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.metabol.2024.156054_bb0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/mp700103m","article-title":"Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response","volume":"5","author":"Moreau","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1016\/j.metabol.2024.156054_bb0270","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear receptor PXR, transcriptional circuits and metabolic relevance","volume":"1812","author":"Ihunnah","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2024.156054_bb0275","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/nar\/gkn1047","article-title":"Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes","volume":"37","author":"Hariparsad","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2024.156054_bb0280","doi-asserted-by":"crossref","first-page":"30075","DOI":"10.1074\/jbc.M114.578781","article-title":"Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells","volume":"289","author":"Wang","year":"2014","journal-title":"J Biol Chem"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T10:18:59Z","timestamp":1733825939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524002828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"alternative-id":["S0026049524002828"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156054","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156054"}}